<scp>GLP</scp> ‐ <scp>1RAs</scp> versus metformin and Parkinson's risk in type 2 diabetes
By addressing key limitations of earlier studies through a large-scale, active-comparator, new-user design, this study provides novel evidence of a delayed neuroprotective effect of GLP-1RAs. These findings support incorporating neurologic outcomes into long-term diabetes management and may inform therapy selection in high-risk populations.
Authors
- J. Zhang
- Wan‐Ming Chen (ORCID: https://orcid.org/0009-0009-6628-0635)
- Xiaoling Wang
- Tian Mao
- Zhongyuan Lu
- Szu‐Yuan Wu
- Shuang Lv
- Mingyang Sun
Institutions
- Fu Jen Catholic University (TW)
- Asia University (TW)
- Luodong Poh-Ai Hospital (TW)
- Zhengzhou University (CN)
- Henan Academy of Sciences (CN)
- Henan Provincial People's Hospital (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1111/dom.70459
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00